These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23973798)
1. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1. Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798 [TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function. Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518 [TBL] [Abstract][Full Text] [Related]
3. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I. Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294 [TBL] [Abstract][Full Text] [Related]
4. Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability. Mishra VK; Palgunachari MN; McPherson DT; Anantharamaiah GM Biochem Biophys Res Commun; 2013 Jan; 430(3):975-80. PubMed ID: 23261466 [TBL] [Abstract][Full Text] [Related]
5. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling. Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845 [TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
7. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304 [TBL] [Abstract][Full Text] [Related]
8. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Gaidukov L; Tawfik DS Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586 [TBL] [Abstract][Full Text] [Related]
9. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes. Mastorikou M; Mackness M; Mackness B Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348 [TBL] [Abstract][Full Text] [Related]
10. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025 [TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein. Cho KH Molecules; 2021 Dec; 26(24):. PubMed ID: 34946565 [TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation, intestine, and paraoxonase-1. Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995 [TBL] [Abstract][Full Text] [Related]
13. The effect of HDL mimetic peptide 4F on PON1. Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879 [TBL] [Abstract][Full Text] [Related]
14. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly. Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623 [No Abstract] [Full Text] [Related]
15. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659 [TBL] [Abstract][Full Text] [Related]
16. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. Sparks DL; Lund-Katz S; Phillips MC J Biol Chem; 1992 Dec; 267(36):25839-47. PubMed ID: 1464598 [TBL] [Abstract][Full Text] [Related]
17. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation. Hine D; Mackness B; Mackness M IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096 [TBL] [Abstract][Full Text] [Related]